Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I5HE
|
||||
Former ID |
DPR000082
|
||||
Drug Name |
NPY5RA-972
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Obesity [ICD9: 278; ICD10:E66] | Preclinical | [536122] | ||
Company |
AstraZeneca
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H25N3O2
|
||||
Canonical SMILES |
CC1=C(C=CC2=C1C3=CC=CC=C3N2C(C)C)NC(=O)N4CCOCC4
|
||||
InChI |
1S/C21H25N3O2/c1-14(2)24-18-7-5-4-6-16(18)20-15(3)17(8-9-19(20)24)22-21(25)23-10-12-26-13-11-23/h4-9,14H,10-13H2,1-3H3,(H,22,25)
|
||||
InChIKey |
ZNFMHLDBJPAFEQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Neuropeptide Y receptor 5 | Target Info | Antagonist | [536122] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.